Juan C Ramos

Trials

Studies that name Juan C Ramos as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 07:51 UTC. Open this list on ClinicalTrials.gov

• Ph1
  NCT05321940 · Safety Trial of STING-dependent Activators and Stimulated Dendritic Cells for Aggressive Relapsed/Refractory Leukemias

  Juan C. Ramos, MD · withdrawn · Refractory Leukemia, Relapsed Leukemia, Acute Myelogenous Leukemia · principal investigator
• Ph2
  NCT02737046 · Belinostat Therapy With Zidovudine for Adult T-Cell Leukemia-Lymphoma

  University of Miami · completed · Adult T-cell Leukemia-Lymphoma, ATLL · principal investigator
• Ph1/Ph2
  NCT01193842 · Vorinostat and Combination Chemotherapy With Rituximab in Treating Patients With HIV-Related Diffuse Large B-Cell Non-Hodgkin Lymphoma or Other Aggressive B-Cell Lymphomas

  National Cancer Institute (NCI) · completed · AIDS-Related Plasmablastic Lymphoma, AIDS-Related Primary Effusion Lymphoma, Ann Arbor Stage I Diffuse Large B-Cell Lymphoma · principal investigator

Grants

NIH projects from RePORTER, fetched 2026-11-12 07:51 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. 7 other NIH projects list an investigator with the same name at a different institution and are left out. Coverage is US federal funding only; UK and EU funders are not searched yet.

• Epigenetic Targeting of Afro-Caribbean Variant of HTLV-1 Related Adult T-cell Leukemia-lymphoma
  R01CA223232 · NCI · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · fiscal years 2018 to 2022 · $330,140 awarded in 2022
  Same name and institution; not confirmed by an ID
• UM CFAR SCCC Argentina Consortium for research and training in Virally Induced AIDS Malignancies
  U54CA221208 · NCI · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · fiscal years 2022 · $488,428 awarded in 2022
  Same name and institution; not confirmed by an ID
• Targeting of EBV Latency in Burkitt's Lymphoma
  R01CA112217 · NCI · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · fiscal years 2008 to 2010 · $236,524 awarded in 2010
  Same name and institution; not confirmed by an ID
• CELLULAR TOXICOLOGY OF THE DOPAMINE NEURON
  K08NS001142 · NINDS · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · fiscal years 1988 to 1990 · $58,316 awarded in 1990
  Same name and institution; not confirmed by an ID

NIH grants that fund their trials

These grant numbers are on the registry records of the trials above. They fund the trial, often through a cooperative group or network, and their principal investigator is usually someone else.

• Consortium for Advancing Management and Prevention of Cancer in People with HIV
  UM1CA121947 · NCI · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI Joseph A. Sparano · fiscal years 2015 to 2026
  Named on NCT01193842